Mergers & Acquisitions

IntegriChain Acquired by Nordic Capital

5991 IntegriChain NT

M&A Engagement Overview

Industry Groups: Healthcare & Life Sciences; Technology
Areas of Focus: HCIT; Pharma & Devices

Harris Williams advised IntegriChain, a portfolio company of Accel-KKR, on their pending sale to Nordic Capital.

Philadelphia-based IntegriChain is a leading provider of pharmaceutical technology, data, consulting, and outsourcing solutions designed to improve how life sciences products reach customers. The company offers the pharma industry a fully integrated platform for commercialization and market access, helping manufacturers bring their science to market while ensuring patients have affordable, timely, and sustainable access to therapy.

IntegriChain has thrived with Accel-KKR's guidance and support, and Nordic is a fantastic partner for IntegriChain as they continue to extend their position as a leading platform for pharma manufacturers.

IntegriChain serves both emerging and large pharma companies and offers its clients unique capabilities that solve critical bottom-line challenges. The company’s proprietary, integrated ICyte platform helps connect the commercial, financial, and operational dimensions of drug access and profitability. ICyte enables pharmaceutical innovators to achieve better commercial outcomes by digitalizing business activities and integrating data and operations across contracting, pricing, and distribution. 

In partnership with Nordic Capital, IntegriChain is well-positioned to extend their position as a leading platform for pharma manufacturers to bring their science to market. 

Contact the Harris Williams Healthcare & Life Sciences Group or Technology Group to learn more about this transaction.